News

28.04.2022
5003 - Anti-Gangliosid Dot
Intended Use The Anti-Gangliosid Dot is a qualitative line immunoassay for the determination of IgG or IgM antibodies against gangliosides in human serum. The Anti-Gangliosid Dot is intended as an aid in the diagnosis of peripheral neurological disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro […]
More details  
20.01.2021
50391 - DotDiver Anti-Gangliosid IgM
Intended Purpose The DotDiver Anti-Gangliosid IgM is a qualitative line immunoassay for the determination of IgM antibodies against gangliosides in human serum. The DotDiver Anti-Gangliosid IgM is intended as an aid in the diagnosis of autoimmune neuropathies in conjunction with other clinical and laboratory findings. The immunoassay is designed for semi-automated use with the DotDiver […]
More details  
20.01.2021
50381 - DotDiver Anti-Gangliosid IgG
Intended Purpose The DotDiver Anti-Gangliosid IgG is a qualitative line immunoassay for the determination of IgG antibodies against gangliosides in human serum. The DotDiver Anti-Gangliosid IgG is intended as an aid in the diagnosis of autoimmune neuropathies in conjunction with other clinical and laboratory findings. The immunoassay is designed for semi-automated use with the DotDiver […]
More details  
20.01.2021
50301 - DotDiver Anti-Gangliosid screen
Intended Purpose The DotDiver Anti-Gangliosid screen is a qualitative line immunoassay for the determination of IgG and IgM antibodies against gangliosides in human serum. The DotDiver Anti-Gangliosid screen is intended as an aid in the diagnosis of autoimmune neuropathies in conjunction with other clinical and laboratory findings. The immunoassay is designed for semi-automated use with […]
More details